Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q1 EPS of $0.68, $0.07 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $598.1 million versus the consensus estimate of $631.09 million.
GUIDANCE:
Globus Medical sees FY2025 EPS of $3.00-$3.30, versus the consensus of $3.40. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.73 billion.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- First Busey (BUSE) Misses Q3 EPS by 4c
- First Carolina Financial Services, Inc. (FCBM) Reports Q3 EPS of $0.26
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
